Macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene

Toxicol Appl Pharmacol. 1986 Mar 30;83(1):95-100. doi: 10.1016/0041-008x(86)90326-1.

Abstract

In the present study exposure to 1,3-butadiene (BD) resulted in a macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic inhalation of 1250 ppm for 6 to 24 weeks. Treatment-related changes evident after 6 weeks of exposure included a decrease in circulating erythrocytes, total hemoglobin, and hematocrit and an increase in mean corpuscular volume. A leukopenia, due primarily to a decrease in segmented neutrophils, and a five- to sixfold increase in circulating micronuclei were observed after 6 and 24 weeks of exposure. These changes were not accompanied by a significant alteration in mean corpuscular hemoglobin concentration, an increase in circulating reticulocytes, or circulating nucleated erythrocytes. A consistent treatment-related alteration in bone marrow cellularity was not found. However, flow cytofluorometric analysis of bone marrow DNA cell cycle kinetics revealed a 44% increase in proliferative index relative to controls, due primarily to an increase in the proportion of cells in S phase. These findings are consistent with a treatment-related macrocytic-megaloblastic anemia and indicate the bone marrow to be an important target organ for BD toxicity.

MeSH terms

  • Anemia, Macrocytic / chemically induced*
  • Anemia, Megaloblastic / chemically induced*
  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / pathology*
  • Butadienes / toxicity*
  • DNA / analysis
  • Erythrocyte Count / drug effects
  • Hematocrit
  • Hemoglobins / analysis
  • Leukocyte Count / drug effects
  • Male
  • Mice
  • Mice, Inbred Strains
  • Mutagens / toxicity*
  • Platelet Count / drug effects

Substances

  • Butadienes
  • Hemoglobins
  • Mutagens
  • DNA
  • 1,3-butadiene